AnaSpec’s Published References Passes 600
News May 05, 2008
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 600. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis reagents.
Director of Sales & Marketing, Violeta Rajkovska stated, “This year has seen the fastest accumulation of published references in AnaSpec’s history. For the past 15 years, we have been honored to be the vendor of choice for some of the world’s most respected researchers.”
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.